Back in 2017, Jujuy was one of the 17 Argentine provinces to support Bill 27.350 on “Medical and Scientific Research for Medicinal Use of the Cannabis Plant and its Derivatives.” That same year, in order to start a medical cannabis project, the provincial state-owned company, Cannava SE, was founded.
Today, the company (the only that’s fully operational in the country) manages 35 active cultivation hectares that produce 2,000 cannabis plants. However, the northern province recently presented a project in front of numerous ministers, proposing an expansion of the workspace to 600 hectares.
To understand the implications of the expansion and the objectives of this government project, El Planteo interviewed Gastón Morales, president of the state-owned company.
Objective And Strategy
Gastón Morales states that the main objective of the Cannava project and its proposed expansion is “to consolidate Jujuy as a hub for scientific and biotechnological development associated with the development of the medical cannabis industry.”
This objective takes several dimensions.
In the first place, the goal is for “the state company to produce medical grade cannabis derivatives that are safe, controlled and affordable for the people, and competes in quality with the products manufactured today at an international level,” Morales explains.
In terms of public health, this would help meet the population’s medical demands, which are currently unsatisfied.
For second, it is essential to understand cannabis is a global industry, advancing by leaps and bounds, Morales says. For this reason, the northern province aims to “insert itself into this global growth projection, opening up the possibility of exporting industrialized products to other countries.”
These exports would translate into a powerful inflow of foreign currency that would largely benefit the province’s economy.
Thirdly, the enormous labor possibilities that this project will entail must be thoroughly considered:
“The entire …